Free Trial

Schrödinger, Inc. (NASDAQ:SDGR) Given Average Recommendation of "Buy" by Analysts

Schrödinger logo with Medical background

Schrödinger, Inc. (NASDAQ:SDGR - Get Free Report) has been given a consensus rating of "Buy" by the six analysts that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, four have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $32.80.

Several brokerages have recently weighed in on SDGR. KeyCorp upped their price target on Schrödinger from $30.00 to $32.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. Piper Sandler reduced their price objective on shares of Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th.

Check Out Our Latest Research Report on Schrödinger

Insiders Place Their Bets

In other Schrödinger news, insider Karen Akinsanya sold 16,723 shares of the firm's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $25.09, for a total transaction of $419,580.07. Following the sale, the insider now owns 15,625 shares in the company, valued at $392,031.25. This trade represents a 51.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Geoffrey Craig Porges sold 5,491 shares of Schrödinger stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $21.76, for a total value of $119,484.16. Following the sale, the chief financial officer now directly owns 27,544 shares of the company's stock, valued at approximately $599,357.44. This trade represents a 16.62% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 8.60% of the company's stock.

Hedge Funds Weigh In On Schrödinger

Several institutional investors have recently modified their holdings of the company. Greenwood Capital Associates LLC increased its stake in Schrödinger by 2.7% in the 1st quarter. Greenwood Capital Associates LLC now owns 23,139 shares of the company's stock worth $457,000 after buying an additional 612 shares in the last quarter. United Advisor Group LLC boosted its stake in shares of Schrödinger by 3.3% in the fourth quarter. United Advisor Group LLC now owns 19,769 shares of the company's stock worth $381,000 after acquiring an additional 634 shares during the period. PNC Financial Services Group Inc. grew its position in shares of Schrödinger by 29.9% during the first quarter. PNC Financial Services Group Inc. now owns 2,956 shares of the company's stock worth $58,000 after purchasing an additional 680 shares in the last quarter. Redwood Wealth Management Group LLC grew its position in shares of Schrödinger by 8.4% during the fourth quarter. Redwood Wealth Management Group LLC now owns 14,620 shares of the company's stock worth $283,000 after purchasing an additional 1,132 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Schrödinger by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,643 shares of the company's stock valued at $610,000 after purchasing an additional 1,202 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Schrödinger Trading Down 2.3%

Schrödinger stock opened at $23.36 on Friday. The firm has a 50 day simple moving average of $22.85 and a 200 day simple moving average of $21.93. Schrödinger has a 1-year low of $16.60 and a 1-year high of $28.47. The firm has a market capitalization of $1.71 billion, a price-to-earnings ratio of -9.98 and a beta of 1.84.

Schrödinger (NASDAQ:SDGR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.82) EPS for the quarter, missing analysts' consensus estimates of ($0.81) by ($0.01). Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The company had revenue of $59.55 million during the quarter, compared to the consensus estimate of $54.60 million. During the same period in the previous year, the business earned ($0.86) earnings per share. Schrödinger's revenue was up 62.7% on a year-over-year basis. On average, equities research analysts forecast that Schrödinger will post -2.37 EPS for the current year.

About Schrödinger

(Get Free Report

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.

Featured Articles

Analyst Recommendations for Schrödinger (NASDAQ:SDGR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Schrödinger Right Now?

Before you consider Schrödinger, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrödinger wasn't on the list.

While Schrödinger currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

New AI Deals Just Sent These 4 Infrastructure Stocks Soaring
7 Nuclear Stocks One Announcement Away from Exploding
3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines